Chemist, QC – 2nd Shift
Viatris
Summary
Every day, we rise to the challenge to make a difference and here's how the Chemist, QC – 2nd Shift role will make an impact:
Job description
Key responsibilities for this role include:
- Performs and documents the analysis of samples following approved test methods.
- Calculate, check, and/or review data.
- Assist with method development, validation, and transfer.
- Assist with instrument calibrations and maintenance.
- May work on analytical projects under direct supervision.
- Attend training classes and seminars as required.
The minimum qualifications for this role are:
- Bachelor's degree and 0-2 years of experience. However, a combination of experience and/or education will be taken into consideration.
Requirements
- Bachelor's degree
- 0-2 years of experience
Benefits
- Shift differential
Company overview
Viatris Inc. is a global pharmaceutical company formed in November 2020 through the merger of Mylan and Pfizer's Upjohn division. Headquartered in Canonsburg, Pennsylvania, the company operates with a mission to empower people worldwide to live healthier at every stage of life. Viatris uniquely bridges the traditional divide between generics and branded medicines, combining the best of both approaches to address healthcare needs globally. With approximately 32,000 employees worldwide, the company maintains a diverse portfolio of over 1,400 approved therapeutic molecules across key areas including cardiovascular, infectious diseases, oncology, immunology, CNS and anesthesia, women's healthcare, diabetes and metabolism, gastroenterology, respiratory and allergy, and dermatology. Viatris operates approximately 40 manufacturing sites across five continents, producing oral solid doses, injectables, complex dosage forms, and active pharmaceutical ingredients. The company's global supply chain is designed to reach patients in more than 165 countries and territories, supplying approximately 1 billion patients annually. Viatris focuses on expanding access to high-quality medicines while developing more complex and novel products to address unmet medical needs.